• The Impact and Expectations of GCP Renovation on the Clinical Trial Environment in Japan
  Hiroshi KASANUKI
  2025Volume 56Issue 2 Pages 80-87
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_80
  JOURNAL RESTRICTED ACCESS
  Download PDF (1819K)
• Overview of GCP ICH E6（R3） and MHLW/PMDA Approach toward Improving Environment for Clinical Trials
  Katsuaki URA, Hiromi TAKIZAWA, Ruri MATSUMOTO, Yusuke FUKUDA, Shunsuke ...
  2025Volume 56Issue 2 Pages 88-93
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_88
  JOURNAL RESTRICTED ACCESS
  Download PDF (1687K)
• How GCP Renovation Would Impact Medical Device Development ?
  Haruko YAMAMOTO
  2025Volume 56Issue 2 Pages 94-98
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_94
  JOURNAL RESTRICTED ACCESS
  Download PDF (1658K)
• Adapting to GCP renovation: Medical Institutionʼs Perspective
  Kenichi NAKAMURA
  2025Volume 56Issue 2 Pages 99-102
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_99
  JOURNAL RESTRICTED ACCESS
  Download PDF (1220K)
• Assignments to be Addressed in the Implementation of ICH E6（R3）　－From the Industrial Perspective－
  Mitsuaki AOYAGI
  2025Volume 56Issue 2 Pages 103-108
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_103
  JOURNAL RESTRICTED ACCESS
  Download PDF (1479K)

• [title in Japanese]
  [in Japanese]
  2025Volume 56Issue 2 Pages 109-112
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_109
  JOURNAL RESTRICTED ACCESS
  Download PDF (1466K)
• [title in Japanese]
  [in Japanese]
  2025Volume 56Issue 2 Pages 113-118
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_113
  JOURNAL RESTRICTED ACCESS
  Download PDF (1541K)

• [title in Japanese]
  [in Japanese]
  2025Volume 56Issue 2 Pages 119-121
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_119
  JOURNAL RESTRICTED ACCESS
  Download PDF (1290K)

• Guideline on Good Pharmacovigilance Practices（GVP）in EU　―Risk Minimisation Measures（Module XVI）（Rev 3）―Part 1
  Kazuhiko ISHIDA, Chikako OSUMI, Mao NAKAJIMA, Nobuhiro NARII, Noriko H ...
  2025Volume 56Issue 2 Pages 122-140
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_122
  JOURNAL RESTRICTED ACCESS
  Download PDF (2219K)

• [title in Japanese]
  [in Japanese]
  2025Volume 56Issue 2 Pages 141-148
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_141
  JOURNAL RESTRICTED ACCESS
  Download PDF (2907K)
• [title in Japanese]
  [in Japanese]
  2025Volume 56Issue 2 Pages 149-164
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_149
  JOURNAL RESTRICTED ACCESS
  Download PDF (1499K)

• Citrus Flavone Glycosides as Alternative Reference Standards for TLC Analysis
  Manami HABA, Masayoshi OYAMA
  2025Volume 56Issue 2 Pages 165-171
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_165
  JOURNAL FREE ACCESS
  Download PDF (19374K)
• Research on Revision of the Japanese Pharmacopoeia for International Harmonization of Quantitative Methods
  Genichiro TSUJI, Yosuke DEMIZU
  2025Volume 56Issue 2 Pages 172-182
  Published: 2025
  Released on J-STAGE: April 25, 2025
  
  DOIhttps://doi.org/10.51018/pmdrs.56.2_172
  JOURNAL FREE ACCESS
  Download PDF (2474K)